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TCRc-Chain Gene Rearrangement by PCR-Based
GeneScan: Diagnostic Accuracy Improvement and
Clonal Heterogeneity Analysis in Multiple Cutaneous
T-Cell Lymphoma Samples
Renata Ponti1, Maria T Fierro1, Pietro Quaglino1, Bonello Lisa2, Francia di Celle Paola2, Ortoncelli Michela1,
Fava Paolo1, Alessandra Comessatti1, Mauro Novelli1 and Maria G. Bernengo1
Cutaneous T-cell lymphomas are a heterogeneous group of lymphomas where the tumor population emerges
within a multiple subclone pattern (‘‘clonal heterogeneity’’). PCR analysis has been shown to be useful in the
diagnosis of mycosis fungoides (MF) and Se´zary Syndrome (SS). Focusing the attention on clonal heterogeneity,
the efficacy of the multiplex/heteroduplex (HD) PCR and the GeneScan (GS) capillary electrophoresis analysis
was compared in the early diagnosis of MF/SS, using a multiple sample approach. Indeed, GS demonstrated
TCRg gene rearrangement (GR) in all the 57 SS (100%) and in 123/146 (84%) of the MF samples, whereas the
multiplex/HD PCR was less sensitive. An increase in clonality was observed in connection with both a worsening
of the cutaneous disease (79% T1/T2; 100% T3/T4) and an increase in the histopathological score (HSo5, 76%;
HSX5, 94%). Clonal heterogeneity with adjunctive reproducible skin TCRg-GRs was also observed. ‘‘Clonal
instability,’’ with different GRs, was present in a small percentage of patients. Therefore, it can be concluded that
GS analysis in TCRg-GR is able to improve diagnosis in MF/SS patients and the multiple sample approach is
helpful for a correct interpretation of clonal patterns in skin lesions, especially in early-stage MF and in SS skin/
blood samples.
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INTRODUCTION
Clonal TCR gene rearrangement (GR), demonstrated by PCR,
is the most effective method to evaluate clonality in T-cell
malignant neoplasms. When T cells develop in the thymus,
they rearrange the TCR genes (Hayday et al., 1985). The
g-chain gene, although typically not expressed on the cell
surface, remains rearranged in the T-cell genome and
provides a conventional clonality marker (Theodorou et al.,
1994; Wood et al., 1994a, b). Various PCR methods, based
on different techniques to detect clone-specific PCR products,
have been developed (Beaubier et al., 2000; Sprouse et al.,
2000; Sandberg et al., 2003; Costa et al., 2004). We reported
a multiplex/heteroduplex (HD) PCR method for the detection
of T-cell clonality (Ponti et al., 2005). This method, used
routinely on cutaneous T-cell lymphomas (CTCL), offers a
rapid and practical tool with a high specificity (97.7%) and
sensitivity (83.5%) (Ponti et al., 2005). However, sensitivity
reached 100% only at the tumor stage and erythrodermic
mycosis fungoides (MF) (T3/T4) stage, whereas it was lower in
the early stages (T1, 71.4%; T2, 76.1%).
There is increasing evidence that CTCL are a hetero-
geneous group of lymphoid malignant neoplasms, in which
the tumor population, of monoclonal origin, emerges
frequently within a multiple subclone pattern.
Rubben et al. (2004) studied the mutation pattern within
microsatellite DNA and suggested that the tumor cell
population in MF is often made up of multiple subclones
and that tumor evolution in CTCL may display multilineage
progression. Only a few studies have analyzed the influence
that clonal heterogeneity has on the correct interpretation of
clonal pattern and, consequently, on the diagnosis of CTCL
samples (Dippel et al. 2001; Klemke et al., 2002, 2006).
These data prompted us to conduct a prospective study of
cutaneous T-cell clonality in a large series of 270 biopsies
from patients with a final diagnosis of either CTCL (141) or
chronic benign inflammatory dermatoses (ID; 55) and in
blood samples from erythrodermic patients with a clinical
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suspicion of Se´zary syndrome (SS). The TCRg-GR was studied
by PCR and GeneScan (GS) analysis using fluorescently
labelled PCR primers and capillary electrophoresis. Although
GS protocol allows an accurate comparative evaluation of
the size and V-family type of clonal TCRg-GR products, only
a few studies, on a limited number of CTCL samples, are
available (Dippel et al., 1999, 2001; Sprouse et al., 2000;
Assaf et al., 2000; Klemke et al., 2002; Lukowsky et al., 2002;
Vega et al., 2002; Sandberg et al., 2003; Costa et al., 2004).
The PCR results were analyzed and compared to the clinical
diagnosis, the stage of the disease, the histopathological score
(HS), according to Guitart et al. (2001), as well as to the
immunophenotypical data.
Our aim was to determine if this method combined with
multiple sample approach may be useful to enhance the
sensitivity of CTCL diagnosis and to overcome the bias
related to the influence clonal heterogeneity has on the
correct interpretation of the sample clonal patterns.
RESULTS
A prospective investigation of DNA isolated from skin
specimens of 196 patients submitted for the determination
of T-cell clonality, in support of clinical suspicion of CTCL,
was carried out. Two or more skin biopsies were available in
58 (29%) patients (Table 1). A total of 270 skin biopsies were
analyzed, confirming suspicion of CTCL by histology in 178
samples (66%). Fifty-eight samples were classified as
inflammatory dermatoses (psoriasis, contact dermatitis, ato-
pic dermatitis, drug reaction) on the basis of histological data
and clinical findings. The remaining 34 samples were initially
considered non-diagnostic, as their clinicopathological fea-
tures were not consistent with either MF or any specific type
of inflammatory dermatosis (ID). Twenty-five of these
samples were harvested from patients with a previous or
subsequent histological diagnosis of MF/SS, and 18 of them
were reclassified as ‘‘early MF/SS’’ owing to the rescue of a
specific clonal stable population by the multiple sample GS
analysis (Tables 1 and 2).
Multiplex/HD analysis
All the samples (n¼ 270) were assessed for T-cell clonality
using both multiplex/HD PCR and GS analysis (Table 2). A
dominant clone was found by Multiplex/HD PCR analysis in
98/146 (67%) and in 49/57 (86%) of total samples from MF
and SS patients, respectively. As reported previously (Ponti
et al., 2005), there was a higher percentage of clonal cases in
the samples from MF subjects, not only with the worsening of
the disease (60% T1/T2 vs 89% T3/T4, Po0.001), but also
with the increase of HS (HSo5, 53%; HSX5, 85%;
Po0.0001). Noteworthy is the high clonality demonstrated
in 23/29 (79%) T1/T2 samples with an HSX5.
A T-cell clone was observed in 3/58 samples with a
histological diagnosis of inflammatory dermatosis (ID) and in
14/33 lesions with a non-diagnostic histological pattern.
Interestingly, 9/14 samples were obtained from patients with
a previous or subsequent diagnosis of CTCL and successively
reclassified in the group of ‘‘early MF/SS’’ cases.
GS analysis
The dilution series analysis of two clonal V-b-TCR (TCR-
Vbþ ) samples with biallelic GRs (biallelic VgI-Jp GR;
biallelic VgI-Jg/VgII-Jg GR) showed that the sensitivity differs
if the test is used for the detection of minimal residual disease
(MRD) of a known monoclonal population, rather than for the
identification of a new unknown population. Indeed, a
sensitivity of 1 and 5% dilution was observed in the two
series of TCR-Vbþ sample dilution, used to detect an
unknown clonal population. On the contrary, the MRD
approach demonstrated the persistence of a known clonal
rearrangement at a dilution of 0.1% in the first sample
(biallelic VgI-Jp GR) and of 0.5–1% in the second (biallelic
VgI-Jg/VgII-Jg GR).
A higher percentage of clonal cases was detected by GS
than by multiplex/HD PCR (Table 2) in all the 57 biopsies
from SS patients (100%) and in 123/146 (84%) MF samples.
As already demonstrated with multiplex/HD analysis, the
percentage of clonal cases in MF group increased, not only
with the worsening of the cutaneous disease (79% T1/T2 vs
100% T3/T4), but also with the increase in the HS (HSo5,
76%; HSX5, 94%). Indeed, the T1/T2 samples with an
HSX5 showed a high clonal pattern (25/29, 86%). Clonality
could not be detected in any of the ID samples, whereas a
T-cell clone was observed in 20/33 non-diagnostic histo-
logical samples; interestingly, 18 of these had been obtained
from patients who showed a final diagnosis of MF/SS during
followup.
Table 1. Immunopathological diagnosis on skin samples (n=270)
Immunopathological diagnosis on skin samples
Non-diagnostic ID MF SS Samples
Patient’s disease Patients Unclassifiable Reclassified (early CTCL)
ID 55 9 58 67
MF 108 7 11 128 146
SS 33 7 50 57
Total 196 16 18 58 128 50 270
ID, inflammatory dermatoses; MF, mycosis fungoides; SS, Se´zary syndrome; non-diagnostic: samples with clinical and histopathological features not
consistent with either MF or any specific type of inflammatory disease; reclassified early CTCL: samples with clinical and histopathological features not
consistent with MF/SS or ID but with rescue of a stable clonal population by multiplex sample GS analysis.
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As each Vg family primer was labelled with a different
fluorescent dye, it was possible to identify the Vg family used
in each clonal TCRg-GR: VgI was the most common Vg
family (75%) observed in MF and SS, followed by VgIII/IV
(24%) and VgII (7%). Two rearranged alleles were observed
in 57 (40%) of the CTCL patients.
GS on multiple skin biopsies
A total of 132 multiple skin biopsies were analyzed to further
investigate clonal heterogeneity. Among them, 109 were
taken from 47 CTCL patients (27 MF, 20 SS), whereas the
remaining 23 were performed in 11 non-CTCL patients who
were compared as to their clonal TCRg-GR pattern. A patient
was considered to have a ‘‘stable clonal pattern’’ when a
stable and common TCRg-GR was present in multiple skin
samples. An ‘‘unstable clonal pattern’’ was defined by the
rescue of different prominent GRs in sequential samples from
the same patient. A patient was considered to have a ‘‘clonal
heterogeneity’’ when a common TCRg-GR was concomitant
to additional reproducible GRs in multiple samples. If the
exact size of a prominent TCRg-GR peak was not confirmed
on two or more repeated GS-PCR runs of the same sample,
the case was regarded as pseudo-monoclonal and was
included in the oligo-polyclonal group.
A clonal GR was detected in 107/109 of the samples from
CTCL patients. A stable clonal pattern was demonstrated in
18/47 (38%) CTCL patients, whereas a clonal heterogeneity
occurred in the remaining 29. In the latter group, one patient
showed an unstable clonal pattern.
SS sample GS clonal assessment
Both skin and blood samples of the 33 erythrodermic patients
with a diagnosis of SS were analyzed and compared with
morphological and phenotypic features (Table 3). Clonality
was tested on skin and blood at diagnosis in 30 patients and
repeated on skin (12 patients had repeated biopsies) and
blood at different followup times, whereas the PCR was not
available on blood in 3 patients diagnosed before 1999.
All the patients showed a specific TCRg-GR in the peripheral
blood, also in the presence of a circulating Se´zary cell count
o1,000cellsmm3 (8 patients; Table 3). Conversely, a TCRVb
restriction was detected by flow cytometry only in 19/33 (58%)
subjects.
GS analysis allowed the detection of a clonal population
in all the SS skin biopsies, whereas multiplex /HD PCR failed
to detect the TCRg-GR in at least one skin sample of six SS
patients (patient no. 2, 5, 6, 8, 20, 27). All these patients
showed a mild perivascular infiltrate, confirming that multi-
plex/HD PCR sensitivity is dependent on the extent of the
lymphoid infiltration (Ponti et al., 2005). In these cases, GS
analysis showed the major clonal involvement on blood
compared with skin infiltration (Figure 1).
In two patients who achieved a clinical complete
remission after treatment with mAb anti-CD52, we could
investigate the MRD by means of multiplex/HD PCR and GS:
we noticed that multiplex/HD PCR became negative in one of
these patients when the number of circulating TCR-Vbþ
atypical cells dropped below 50 cellsmm3, whereas GS
always remained positive. In the other patient, we obtained a
GS negativity on blood and skin when circulating TCR-Vbþ
atypical cells were 0.5% or 3 cellsmm3.
A skin clonal heterogeneity with additional reproducible
TCRg-GRs was noted in 16/20 SS patients with repeated skin
biopsies available (80%), 11 of whom had a constant
individual prevalence of common TCRg-GRs in all the skin
and blood samples tested. The identification of the TCRg-GR
was even more difficult in the remaining five patients, owing
to a non-dominant pattern in both skin and blood at
diagnosis. In these cases, identity of the pathological peak
was confirmed by comparing skin and blood patterns during
the followup. Repeated GS analysis performed in four
patients on the sorted TCRg-Vbþ population further con-
firmed this result (Table 3; Figures 1 and 2). No cases of
pseudomonoclonal pattern were observed in SS patients.
MF sample clonal assessment
Multiple samples were available in 27 MF patients. Three out
of 27 patients with multiple biopsies achieved complete
remission after a median followup of 8 years, whereas 10
showed clinical progression. Nineteen are alive with the
disease in course (Table S1).
Clonal heterogeneity was documented in 13/27 (48%) MF
patients. There was no statistically significant correlation
between the TCRg clonal heterogeneity and clinical progres-
sion. Furthermore, an occult but stable clonal TCRg-GR was
identified by comparing the multiple skin samples, confirm-
ing the presence of disease in eight early-stage MF patients
with a non-diagnostic histological picture then reclassified as
early MF samples; sequencing confirmed the clonal TCRg-GR
in these cases (Table S1). To better illustrate the diagnostic
efficacy of the comparison between multiple biopsies,
Figure 3 and Figures S1 and S2 report detailed patient data.
Table 2. T-cell clonality: multiplex/HD PCR and GS
on 270 samples taken from 196 patients
No. of
samples
Clonal HD,
no. (%)
Clonal GS,
no. (%)
Samples from SS patients 57 49 (86) 57 (100)
Diagnostic SS samples 50 46 (92) 50 (100)
Samples from MF patients 146 98 (67) 123 (84)
Diagnostic MF samples 128 92 (72) 112 (87)
Sample score X5 from MF patients 66 56 (85) 62 (94)
Sample score o5 from MF patients 80 42 (53) 61 (76)
Samples from clinical T1/T2 patients 109 65 (60) 86 (79)
Samples from clinical T3/T4 patients 37 33 (89) 37 (100)
Samples with histological score 45
from T1/T2 patients
29 23 (79) 25 (86)
Inflammatory dermatosis (ID) 58 3 (5) 0
Reclassified early CTCL samples 18 9 (50) 18 (100)
Unclassifiable 16 5 (31) 2 (12)
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Briefly, the patient described in Figure 3 had an oligoclonal
pattern in the first non-diagnostic biopsy and two dominant
TCRg-GR peaks in the second (also non-diagnostic) biopsy.
The true TCRg-GR occult in the first biopsy was further
confirmed on a third skin sample, which was diagnostic at
histology. A common clonal TCRg-GR was observed in seven
MF patients and different clonal TCRg-GRs in one case, in a
total of eight patients with simultaneous skin biopsies, taken
from different sites of involvement. Pseudo-monoclonal
(false-positive) pattern occurred in two MF patients and these
samples were than classified as poly/oligoclonal sample by
repeated PCR runs and multiple sample comparison. The
Table 3. Immunophenotype and TCRc GR studies in 33 SS patients
No. Immunophenotype L per mm3
SS per
mm3 SS%
GS TCRc GR (bp), skin and
blood HD skin
GS on skin cell suspension1
or blood-sorted vb+ cells2
1 CD7+CD26 1,066 234 22 VIIgJg (261) + + (2106)2
2 TCRVb21CD2+/ CD3+/CD7+/CD26 1,991 358 18 VIII/IVgJp(267)VIgJp(271) +
3 CD3+dimCD7+/CD26 2,608 652 25 VIII/IVgJp (267) +
4 TCRVb22+CD26 4,326 692 16 VIgJg(299)VIgJg(296) +
5 TCRVb22+CD3dimCD7CD26 4,095 737 18 VIgJg (283) OLIGO +(19%)1
6 TCRVb17+CD2dimCD7CD26 1,938 814 42 VIgJp(269)VIII/IVgJg(304) POLI +(22%)1; +(2.7 106)2
7 TCRVb5.1+CD2dimCD3dim CD7+CD26 1,818 818 45 VIgJg (291) VIgJp(258) + +(49%)1
8 TCR Vb3.1+CD7+CD26/+ 3,659 878 24 VIgJg (292) VIgJg(305) POLI +(19%)1
9 TCRVb6.7+CD2dimCD7CD26 2,134 1,003 47 VIgJp (266) VIgJg (298) +
10 CD7+CD26 2,026 1,134 56 VIgJp(259) +
11 CD3dimCD7CD26 3,429 1,269 37 VIII/IVgJp(263) +
12 CD2+dimCD3+CD4+dimCD7+CD26 3,446 1,378 40 VIIgJg(251) +
13 TCRVb13.1+CD2dimCD7CD26 2,236 1,431 64 VIgJg (296)VIgJg (262) +
14 TCRVb5.2/5.3+CD3dimCD7+CD26 2,561 1,434 56 VIIgJp(263) +
15 TCRVb6.7+CD3dimCD7CD26 3,518 1,583 45 VIII/IVgJg(294) +
16 CD7+CD26 3,255 1,660 51 VIgJg(297) + +(1.7106)
17 CD2+dimCD3+dimCD7+CD26 3,801 2,395 63 VIgJg (296)VIgJg (299) + +
18 CD2dimCD7dimCD26CD45RA+ 3,600 2,598 65 VIJg (283)VIIJg (257) + +(76%)1; +(1.3 106)2
19 TCRVb16+CD3+dimCD7CD26/+ 4,661 3,030 65 VIgJg (296)VIgJg (299) +
20 TCRVb17+CD2dimCD7CD26 4,708 3,625 77 VIgJg (284) OLIGO
21 TCRVb13.2+CD2dimCD4dimCD26 4,966 3,973 80 VIIgJp(225) +
22 CD7+CD26 5,569 4,455 80 VIII/IVgJp(264) +
23 CD4+dimCD7CD267 10,848 6,075 56 VIgJg(297) +
24 CD7+CD26 6,603 6,339 96 VIgJg (297)VIgJp (265) +
25 CD7+CD26 8,226 6,581 80 VIg(300)VIg (294) +
26 CD7+CD26 8,505 7,144 84 VIpJg(262) VIII/IVgJp(267) +
27 TCRVb2+CD3+dimCD7CD26 9,053 7,514 83 VIgJp(263)VIgJp(264) OLIGO
28 TCRVb6.7+CD3+brightCD26 11,316 9,053 80 VIgJg(298) +
29 TCRVb6.7+CD27CD7CD26 12,454 11,084 89 VIgJg(293) +
30 TCRVb20+CD3+dimCD7CD26 15,939 15,301 96 VIgJg(290) +
31 CD3+dimCD7CD26 31,493 30,863 98 VIgJg(287)VIgJg(298) +
32 TCRVb9+CD77CD26 53,036 50,384 95 VIgJp(263)VIgJp(270) +
33 CD3+dimCD7CD26 5,789 3,994 69 VIgJp(260) +
bp, base pair; HD skin, multiplex/HD PCR results from skin samples; L per mm3, absolute lymphoid cells number per mm3; SS per mm3, absolute SS cells
number per mm3; % SS, Se´zary cells percentage on lymphoid cell; TCRg GR, TCR g gene rearrangement.
1Values in parentheses denote the percentage of atypical clonal cells within the total extracted lymphoid cells (from 20,000 to 115,000).
2Values in parentheses denote the number of cells sorted.
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rescue of a pseudo-monoclonal pattern is increased in blood
samples (data not shown) leading to stress the importance of
repetitive analysis and multiple sample approach.
ID GS clonality
A polyclonal/oligoclonal pattern was documented in 55/58
(95%) patients with skin IDs. Two erythrodermic patients
showed a clonal TCRg-GR coupled with discordant clinical
and histopathological data. The first patient showed the
persistence of a low and stable component of the clonal
TCRg-GR population both in skin and blood, and clinical
examination evidenced the persistence of erythroderma. The
second patient had persistent erythroderma and two non-
diagnostic biopsies showed the onset of a small clonal TCRg-
GR in the second skin biopsy, whereas blood remained
constantly polyclonal. Although there was an initial suspicion
of clonal TCRg-GR at multiplex/HD PCR analysis in another
patient, GS analysis documented an oligoclonal pattern.
Pseudo-monoclonal, false-positive results were obtained in
13 ID patients; repeated PCR runs and multiple sample
comparison allowed reclassification of these cases as
oligoclonal samples.
When all the non-diagnostic skin samples were consid-
ered as a whole, based on clinical outcome and all the
available diagnostic techniques, there was a significant
correlation between the finding of a clonal TCRg-GR and
the final diagnosis of CTCL (P¼ 0.02).
DISCUSSION
PCR analysis for the detection of lymphoid clonality in
clinical specimens has proven to be a useful and reliable
technique in the diagnosis of CTCL. Moreover, the impor-
tance of a highly sensitive method to evaluate the clonality in
these diseases has been stressed (Vega et al., 2002; Rubben
et al., 2004), also to avoid the bias related to the frequent
occurrence of oligo-/pseudo-clonal activation. However,
only a few molecular studies on relatively low numbers of
patients have reported clonal heterogeneity in CTCL (Bignon
and Souteyrand, 1990; Dippel et al., 2001; Vega et al., 2002;
Rubben et al., 2004). Although the underlying mechanism of
genetic instability in MF is still not yet fully clear, it is thought
that it most probably evolves through a combination of clonal
expansion (Dommann et al., 1996; Muche et al., 2003).
Recently, the same authors stressed the importance of
multiple PCR runs to avoid the problem of pseudo-
monoclonality on single samples and the problematic
biological interpretation of the rescue of T-cell clonality of
undetermined significance over all blood samples (Dippel
et al., 2001; Klemke et al., 2002; Vega et al., 2002).
In this study, the PCR product detection was carried out by
multiplex/HD PCR and GS analysis capillary electrophoresis
on skin samples obtained from a large series of CTCLs (141
patients) in an attempt to combine the advantages of high
sensitivity with accurate quantification and size determina-
tion. In the presence of a clinical suspicion of SS, GS was also
carried out on blood samples.
The association between histological features and clonal
evaluation was confirmed independently of cutaneous
T-score with both methods. Indeed, there was no statistical
difference in the percentage of clonal cases between the T1/
T2 and T3/T4 specimens that shared a similar HS (HS5;
P¼0.02). Sensitivity in early-stage lesions appeared to
be higher when the GS method was used than when the
multiplex/HD PCR was used. In fact, considering all the
diagnostic and non-diagnostic samples from the early-stage
T1/T2 MF patients, multiplex/HD PCR revealed clonality in
60% of cases, whereas the percentage rose to 79% using GS.
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Figure 1. SS patient no. 7. (a) Ambiguous GS pattern in skin biopsy at
diagnosis; (b) biallelic TCRg-GR (*) confirmed by comparison with blood
pattern at diagnosis; (c) GS on sorted CD4þCD26Vb5.1þ circulating
lymphocytes; (d) GS on sorted CD4þCD26TCR-Vb5.1 circulating
lymphocytes.
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Figure 2. SS patient no. 1. (a) Ambiguous GS pattern in skin biopsy at
diagnosis; TCRVgII GR (*) confirmed by comparison with blood pattern; (b)
GS pattern in blood sample at diagnosis showing a pathological GR (*) and a
concomitant transient GR (**); (c) TCRVgII clonal GR in the second skin
sample.
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The difference in sensitivity between the two methods was
even more evident in the specimens with a low lymphoid
infiltrate and an HSo5 (from 53 to 76%). On the contrary,
the difference was less evident in advanced-stage MF samples
(from 85 to 94%, respectively, in samples with an HS45).
Our dilution experiments revealed a high in vitro
sensitivity of TCRg-PCR GS analysis. Percentages as low as
1–5%, or at times even lower (0.5–1%), using an MRD
approach, were observed. However, few studies on CTCL
carried out using GS report varying sensibility levels, ranging
from 1 to 6%, depending on the amounts of oligo/polyclonal
background and the Vg family evaluated (Delfau-Larue et al.,
2000; Murphy et al., 2000; Lukowsky et al., 2002; Vega et al.,
2002; Klemke et al., 2002). Indeed, there are a number of
factors that may affect the sensitivity of the method. One such
factor is the competition created during the aspiration phase
in capillary electrophoresis by the electrostatic fields gener-
ated owing to the different size of the various PCR products.
Another variability factor is the difference in primer sensitivity
that may influence the yield of specific PCR products (Vega
et al., 2002). Moreover, only a few studies have taken into
consideration the analysis of clonal variability of these
pathologies by comparing multiple cutaneous lesions. Our
long-term experience in MF/SS skin lesions showed that the
absence of clonal dominance in oligoclonal background,
coupled with the problem of suspicious pseudo-monoclon-
ality in single sample, is not an uncommon finding, especially
in the early stage of the disease. Therefore, whenever
possible, a multiple sample approach was applied, confirm-
ing the clonal population by sequencing and by GS on cell
sorting.
A high prevalence of oligoclonal TCRg-GR pattern, rather
than a polyclonal GR pattern was observed in skin lesions, as
already reported in early MF lesions (Klemke et al., 2002;
Lukowsky et al., 2002; Vega et al., 2002). It has been
suggested that the super-antigen stimulation has some role
(e.g., bacterial proteins) in driving early proliferation of T
cells to the skin in CTCL. Oligoclonal cytogenetic abnorm-
alities have also been described in MF (Schlegelberger et al.,
1994). Clonal heterogeneity with adjunctive reproducible
skin TCRg-GRs was observed in multiple lesions in a large
proportion of CTCL patients. Adjunctive TCRg-GRs were also
observed in peripheral blood during the followup of SS
patients. The temporary dominance of transient clones and
the problem of pseudo-monoclonality results on single
sample could be misleading and could lead to incorrect
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Figure 3. CD3 expression and corresponding GS analysis in MF patient no. 9. (a, d) The first non-diagnostic biopsy showing an oligoclonal pattern; (b, e)
second biopsy with borderline histopathology showing the stable clonal TCRg-GR 296VgIII/IV Jg (*) and a dominant transient VgIJg GR (**); (c, f) third biopsy
with a massive infiltrate confirming the clonal VgIII/IV Jg GR (sequence: Vg10Jg2); (d–f) CD3 staining showing a progressive increase in dermal and epidermal
lymphoid infiltrate in the three consecutive samples.
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identification of the pathological population unless results are
analyzed with repeated PCR runs on the same sample and
compared with multiple skin and blood results.
Indeed, our results showed 80 and 48% of clonal
heterogeneity in SS and MF patients, respectively. These
figures are higher than those reported by Vega et al. (2002),
who obtained about 30% heterogeneity in MF patients. The
reasons for these discrepancies are still unknown, and further
studies are needed to give more insights. Clonal hetero-
geneity has been found both in early and advanced MF
lesions. The nature of the heterogeneity may differ in the
following two conditions: genetic heterogeneity in early-
stage MF may reflect a mixing of tumor clones and reactive
cells in cutaneous lesions (Dommann et al., 1996; Muche
et al., 2003; Delfau-Larue et al., 2000), whereas the onset of a
new stable GR in advanced lesions with a monoclonal
dominant pattern and a low background could be due to the
selection of a new clonal population. Noteworthy is the fact
that, in many CTCL patients with clonal heterogeneity, only
the availability of multiple biopsies allowed correct identifi-
cation of the stable pathological clone. A few cases showed a
clonal instability with different GRs in sequential MF/SS skin
or SS blood samples from the same patients. Expanding
clonal population on blood could be explained also by
reactive anti-tumor populations or age-related expanding
cells, as reported previously by Muche et al. (2003) Recently,
the importance of multiple PCR runs has been stressed by
Klemke et al. (2006) with the aim to get further insights into
the biological problem of peripheral T-cell clonality of
undetermined significance in the absence of a skin clonal
rescue.
In conclusion, the high resolution and specificity obtained
by the use of GS analysis for TCRg-GR combined with the
multiple sample approach enhance the early diagnosis in MF/
SS patients. GS analysis could also be a useful tool for the
detection of MRD in selected cases after therapy. In the
future, the TCRg-GR technique could be further improved by
the use of standardized primers and protocols.
MATERIALS AND METHODS
Patients and biopsy specimens
The present study was performed in compliance with the principles
of good clinical practice and according to the Declaration of
Helsinki Principles. The study protocol was approved by the
responsible Institutional Board. All the patients were included after
providing their written informed consent. The diagnosis of MF was
made according to the standard clinical and immunopathological
findings (Willemze et al., 1997). MF patients were classified
according to the modified tumor, node, metastasis (TNM) staging
of the Mycosis Fungoides Cooperative Group (Kashani-Sabet et al.,
2001). The morphological and cytoarchitectural pattern in MF
diagnostic samples was evaluated according to the nine-point HS
proposed by Guitard et al. as reported previously (Ponti et al., 2005).
The SS diagnostic criteria included (i) erythroderma and peripheral
lymphadenopathies, (ii) peripheral blood involvement by circulating
Se´zary cells, and (iii) cutaneous biopsy-proven CTCL. Peripheral
blood involvement was defined on the basis of the criteria reported
by the International Society of Cutaneous Lymphomas (Vonderheid
and Bernengo, 2003). Peripheral blood immunophenotype and
clonal TCR-Vb expression were also assessed to characterize better
the pathological population (Bernengo et al., 2001). At initial
diagnosis, absolute circulating Se´zary cells at diagnosis were
o1,000 cellsmm3 in eight patients; the percentage of atypical
cells ranged from 16 to 95% of total lymphocytes.
The biopsy specimens were divided into two parts: one was used
for histological evaluation on paraffin-embedded sections and the
other was cryopreserved for immunohistochemical staining and later
used for TCR-g clonality studies. Immunohistochemical staining on
5mm fresh frozen tissue sections was performed in all cases by the
standard streptavidin–biotin–peroxidase method (LSAB2plus Kit,
Dako, Glostrup, Denmark), using a wide panel of mAbs directed
against the T-cell lineage, as well as activation and proliferation
antigens. Immunohistochemical staining was used to define better
the histological score and loss of antigens.
Moreover, tissue suspension for immunofluorescent analysis was
performed by mechanical desegregation with enzymatic treatment
as reported previously, in five SS patients (Novelli et al., 2000).
Peripheral blood lymphocyte flow cytometry
Peripheral blood lymphocytes were analyzed, according to their
immunofluorescence reactivity, using a FACSCalibur cytometer
(Becton Dickinson, San Jose´, CA) equipped with a 15mW,
488nm, air-cooled argon–ion laser and a second red diode laser at
635 nm for allophycocyanin-antibody detection. Three- or four-color
immunofluorescence analyses were performed simultaneously using
FITC-, phycoerythrin-, peridinin chlorophyll protein-, and allophy-
cocyanin-conjugated antibodies as described previously (Bernengo
et al., 2001). A wide panel of mAbs directed against T-cell antigens
was routinely tested. Clonal TCR rearrangement was identified using
a panel of 28 mAbs directed against the variable regions of b-chain
(Serotec Ltd, Oxford, UK; Immunotech Coulter Company, Marseille,
France; Endogen, Cambridge, MA).
Identification of clonal TCRc-GR
Genomic DNA was extracted from 15–20 OCT-cryopreserved tissue
sections (20 mm) and from peripheral blood lymphocytes after
centrifugation with Ficoll–Hypaque (Nycomed, Oslo, Norway) using
a QIAgen tissue kit (QIAamp DNA Mini Kit; QIAGEn GmbH,
Hilden, Germany) according to the manufacturer’s instructions.
TCRg-GR was studied by multiplex/HD PCR on PAGE and GS
capillary electrophoresis analysis. Both multiplex/HD PCR and
GS-PCR were repeated by two separate runs in all CTCL and ID
samples at diagnosis and during followup. Moreover, each sample
had been processed by GS together with all the previous specimens
of the same patient to allow semiquantitative comparison of clonal
population.
The same primers, consensus and specific for each Vg or Jg
segment family, were used in both the protocols (Bottaro et al.,
1994). The multiplex/HD analysis with two multiplex PCRs contain-
ing all J primers (J1/2, Jp1/Jp2, and Jp) plus VI (V2, 3, 4, 5, 7, and 8)
or VII plus VIII/IV (V9 plus V10/11) respectively was performed and
analyzed as reported previously (Ponti et al., 2005).
To amplify the TCRg-GRs by GS capillary electrophoresis, six
simultaneous PCRs, resulting in PCR products of approximately
250–300 base pairs, were performed and contemporarily processed
in a thermal cycle (model PCR Express, Hybaid, UK). The single PCR
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containing one Vg family fluorescent primer (VI–FAM or VII-HEX or
VIII/IV-NED) plus a Jg primer (Jg1/2 or JgP1/2). PCR conditions were
the same as those of multiplex/HD PCR, with the exception of the
last 9minute extension that was prolonged to 15minutes to
eliminate incomplete PCR product fragments; labelled PCR products
were subjected to GS on the ABI 310 PRISM CE sequencer (PE
Applied Biosystem, Weiterstadt, Germany). Before separation, two
mixtures of PCR products (fluorescent V-family/Jg1/2 products and
fluorescent V-family/JgP1/2 products) were prepared with the
addition of 15 ml of deionized formamide and 0.5 ml of GS 500
ROX internal lane standard (Applied Biosystems). The mixtures were
denatured at 901C for 5minutes and chilled on ice. Each run was
performed at 601C and 15KV with a 5 second injection and
36minute separation time in high-resolution denaturing polyacryl-
amide gel (POP4 polymer; Applied Biosystem). The two runs were
analyzed on the same plot using the GS Software (Applied
Biosystems). To determine the clonality of a PCR product, peak-
height ratio was calculated as reported previously (Luo et al., 2001;
Lukowsky et al., 2002). GS analysis was assessed as clonal in the
case of 1–2 prominent peaks yielding a peak-height ratio42.
Oligoclonal pattern was defined as a non-Gaussian distribution of
three or more prominent peaks. Multiple peaks with a Gaussian
distribution indicated polyclonality. All these molecular patterns
were confirmed if demonstrated in the same sample on two or more
repeated runs. If the exact fragment size of a PCR TCRg-GR product
or its dominance (instable semi-quantitative product dimension)
could not be confirmed on repeated analysis of the same sample, a
multiple sample comparison is needed to distinguish between occult
clonal population and pseudo-monoclonal pattern. The case was
regarded as ‘‘pseudo-monoclonal’’ and was included in the oligo/
polyclonal group when this same multiple approach failed to
demonstrate a PCR product with a stable length or a stable
dominance on background. The fragment lengths and V/J family
rearrangement type corresponding to clonal population were
recorded for the comparison between blood and skin samples, as
well as multiple biopsies.
To determine the sensitivity of the GS technique, we employed
DNA from blood samples of two patients with a detected TCR-Vbþ
population by flow cytometry. The first sample, with 98% of TCR-
Vb19þ monoclonal population and positive V-I/Jgp1/2 GR, and the
second sample, with 95% of TCR-Vb17þ monoclonal population
and positive biallelic V-I/Jg1/2/V-II/Jg1/2 GR, were diluted with a
pool of DNA from skin biopsies of reactive infiltrates at the following
concentrations: 10, 5, 1, 0.5, 0.1, and 0.05%.
Sequence analysis of clonal TCRc-GR
TCRg-GRs were sequenced in eight cases where the common
TCRg-GR was not dominant in GS analysis in the consecutive
biopsies. Each band was then excised from agarose gel and DNA
was purified using the PCR clean-up gel extraction kit (Macherey-
Nagel, Du¨ren, Germany). Sequencing was carried out using the Big
Dye Terminator Cycle Sequencing Ready Reaction Kit (Applied
Biosystems), and the analysis was performed on an ABI 310
automated capillary system (Applied Biosystems), following the
manufacturer’s instructions. All samples were sequenced in both
directions. The sequences were compared with published germline
sequences using the DNAplot on the Internet (http://imgt.cines.fr) to
identify Vg and Jg rearrangements.
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